Aphria Inc (fka APHA)

[FUNMAN]

Aphria (NYSE:APHA) Given a $8.30 Price Target by Jefferies Financial Group Analysts

I really don't like analysts. They never really disclose any DD. I could throw a dart at the wall and pick a PT.


Posted by Janice Underwood on Nov 1st, 2019

https://technewsobserver.com/news/2019/11/01/aphria-nyseapha-given-a-8-30-price-target-at-jefferies-financial-group-updated.html

Aphria (NYSE:APHA) has been assigned a $8.30 price target by equities researchers at Jefferies Financial Group in a research note issued on Tuesday, October 15th, TipRanks reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price target would indicate a potential upside of 64.68% from the company’s current price. Jefferies Financial Group also issued estimates for Aphria’s Q3 2020 earnings at $0.00 EPS and FY2022 earnings at $0.39 EPS.

APHA has been the topic of a number of other research reports. Pi Financial set a $9.00 target price on shares of Aphria and gave the stock a “buy” rating in a research report on Tuesday, October 15th. ValuEngine upgraded shares of Aphria from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Zacks Investment Research lowered shares of Aphria from a “buy” rating to a “hold” rating in a research report on Tuesday, October 8th. Finally, CIBC restated a “sell” rating and set a $6.50 target price on shares of Aphria in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating to the stock. Aphria presently has a consensus rating of “Buy” and an average target price of $11.51.

Aphria stock traded up $0.04 during mid-day trading on Tuesday, reaching $5.04. The company had a trading volume of 47,653 shares, compared to its average volume of 6,602,222. Aphria has a 1 year low of $3.75 and a 1 year high of $13.45. The company has a market capitalization of $1.27 billion, a P/E ratio of -45.77 and a beta of 2.85. The stock’s 50-day simple moving average is $5.46 and its 200-day simple moving average is $6.49.

Aphria (NYSE:APHA) last issued its earnings results on Tuesday, October 15th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.03) by $0.10. The company had revenue of $126.10 million during the quarter, compared to analysts’ expectations of $131.15 million. The firm’s revenue was up 848.1% compared to the same quarter last year. On average, analysts anticipate that Aphria will post 0.07 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Capital Investment Advisory Services LLC boosted its holdings in shares of Aphria by 2,233.3% in the 2nd quarter. Capital Investment Advisory Services LLC now owns 7,000 shares of the company’s stock valued at $43,000 after purchasing an additional 6,700 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Aphria by 153.2% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 39,336 shares of the company’s stock valued at $277,000 after acquiring an additional 23,800 shares during the period. Exane Derivatives raised its stake in shares of Aphria by 333.7% in the 2nd quarter. Exane Derivatives now owns 103,130 shares of the company’s stock valued at $723,000 after acquiring an additional 79,350 shares during the period. CIBC Asset Management Inc raised its stake in shares of Aphria by 7.8% in the 2nd quarter. CIBC Asset Management Inc now owns 125,725 shares of the company’s stock valued at $884,000 after acquiring an additional 9,108 shares during the period. Finally, AE Wealth Management LLC purchased a new position in shares of Aphria in the 2nd quarter valued at $153,000. Institutional investors own 10.93% of the company’s stock.

Aphria Company Profile

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.